{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:02Z","timestamp":1786982762522,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI169239"],"award-info":[{"award-number":["R01AI169239"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA009142"],"award-info":[{"award-number":["CA009142"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40264-025-01641-7","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T06:10:14Z","timestamp":1769407814000},"page":"567-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the Use of Medical Insurance Claims and Electronic Health Records to Measure COVID-19 Vaccination During Pregnancy"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-4992","authenticated-orcid":false,"given":"Matthew M.","family":"Coates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey L.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena G.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flor M.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onyebuchi A.","family":"Arah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette K.","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"1641_CR1","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"N Engl J Med"},{"key":"1641_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2035389.","journal-title":"N Engl J Med"},{"key":"1641_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021;384:2187\u2013201. https:\/\/doi.org\/10.1056\/NEJMoa2101544.","journal-title":"N Engl J Med"},{"key":"1641_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","volume":"385","author":"PT Heath","year":"2021","unstructured":"Heath PT, Galiza EP, Baxter DN, et al. Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N Engl J Med. 2021;385:1172\u201383. https:\/\/doi.org\/10.1056\/NEJMoa2107659.","journal-title":"N Engl J Med"},{"key":"1641_CR5","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1056\/NEJMoa2200674","volume":"386","author":"ED Moreira","year":"2022","unstructured":"Moreira ED, Kitchin N, Xu X, et al. Safety and efficacy of a third dose of BNT162b2 Covid-19 vaccine. N Engl J Med. 2022;386:1910\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2200674.","journal-title":"N Engl J Med"},{"key":"1641_CR6","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1016\/S2214-109X(20)30484-8","volume":"9","author":"MM Taylor","year":"2021","unstructured":"Taylor MM, Kobeissi L, Kim C, et al. Inclusion of pregnant women in COVID-19 treatment trials: a review and global call to action. Lancet Glob Health. 2021;9:e366\u201371. https:\/\/doi.org\/10.1016\/S2214-109X(20)30484-8.","journal-title":"Lancet Glob Health"},{"key":"1641_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejogrb.2022.05.009","volume":"275","author":"O Green","year":"2022","unstructured":"Green O, Young EM, Oberman J, et al. Recruitment of pregnant women to randomised trials of COVID 19 treatments, and pharmaceutical treatments received outside such trials: a research article. Eur J Obstet Gynecol Reprod Biol. 2022;275:12\u20136. https:\/\/doi.org\/10.1016\/j.ejogrb.2022.05.009.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1641_CR8","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.1016\/j.vaccine.2021.09.043","volume":"39","author":"I Bleicher","year":"2021","unstructured":"Bleicher I, Kadour-Peero E, Sagi-Dain L, et al. Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study. Vaccine. 2021;39:6535\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2021.09.043.","journal-title":"Vaccine"},{"key":"1641_CR9","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s41591-021-01490-8","volume":"27","author":"N Dagan","year":"2021","unstructured":"Dagan N, Barda N, Biron-Shental T, et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat Med. 2021;27:1693\u20135. https:\/\/doi.org\/10.1038\/s41591-021-01490-8.","journal-title":"Nat Med"},{"key":"1641_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ijgo.14008","volume":"156","author":"W Fu","year":"2022","unstructured":"Fu W, Sivajohan B, McClymont E, et al. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants. Int J Gynaecol Obstet. 2022;156:406\u201317. https:\/\/doi.org\/10.1002\/ijgo.14008.","journal-title":"Int J Gynaecol Obstet"},{"key":"1641_CR11","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1038\/s41467-022-30052-w","volume":"13","author":"S Prasad","year":"2022","unstructured":"Prasad S, Kalafat E, Blakeway H, et al. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy. Nat Commun. 2022;13:2414. https:\/\/doi.org\/10.1038\/s41467-022-30052-w.","journal-title":"Nat Commun"},{"key":"1641_CR12","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1097\/INF.0000000000004606","volume":"44","author":"AK Regan","year":"2025","unstructured":"Regan AK, Rowe SL. Use of routinely collected \u201creal-world\u201d data for the postlicensure safety assessment of vaccination during pregnancy. Pediatr Infect Dis J. 2025;44:S108. https:\/\/doi.org\/10.1097\/INF.0000000000004606.","journal-title":"Pediatr Infect Dis J"},{"key":"1641_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/cpt.2185","volume":"109","author":"JM Franklin","year":"2021","unstructured":"Franklin JM, Lin KJ, Gatto NM, et al. Real-world evidence for assessing pharmaceutical treatments in the context of COVID-19. Clin Pharmacol Ther. 2021;109:816\u201328. https:\/\/doi.org\/10.1002\/cpt.2185.","journal-title":"Clin Pharmacol Ther"},{"key":"1641_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100616","volume":"4","author":"S Rawal","year":"2022","unstructured":"Rawal S, Tackett RL, Stone RH, et al. COVID-19 vaccination among pregnant people in the United States: a systematic review. Ame J Obst Gynecol MFM. 2022;4:100616. https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100616.","journal-title":"Ame J Obst Gynecol MFM"},{"key":"1641_CR15","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1016\/j.vaccine.2023.05.028","volume":"41","author":"D Surie","year":"2023","unstructured":"Surie D, Bonnell LN, DeCuir J, et al. Comparison of mRNA vaccine effectiveness against COVID-19-associated hospitalization by vaccination source: Immunization information systems, electronic medical records, and self-report\u2014IVY Network, February 1\u2013August 31, 2022. Vaccine. 2023;41:4249\u201356. https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.028.","journal-title":"Vaccine"},{"key":"1641_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.13512","volume":"6","author":"KL Schneider","year":"2023","unstructured":"Schneider KL, Bell EJ, Zhou CK, et al. Use of immunization information systems in ascertainment of COVID-19 vaccinations for claims-based vaccine safety and effectiveness studies. JAMA Netw Open. 2023;6:e2313512. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.13512.","journal-title":"JAMA Netw Open"},{"key":"1641_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0199180","volume":"13","author":"T De Smedt","year":"2018","unstructured":"De Smedt T, Merrall E, Macina D, et al. Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness. PLoS ONE. 2018;13:e0199180. https:\/\/doi.org\/10.1371\/journal.pone.0199180.","journal-title":"PLoS ONE"},{"key":"1641_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251622","volume":"16","author":"U Baum","year":"2021","unstructured":"Baum U, Kulathinal S, Auranen K. Exposure misclassification bias in the estimation of vaccine effectiveness. PLoS ONE. 2021;16:e0251622. https:\/\/doi.org\/10.1371\/journal.pone.0251622.","journal-title":"PLoS ONE"},{"key":"1641_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-3-030-82673-4_6","volume-title":"Applying quantitative bias analysis to epidemiologic data","author":"MP Fox","year":"2021","unstructured":"Fox MP, MacLehose RF, Lash TL. Misclassification. In: Fox MP, MacLehose RF, Lash TL, editors. Applying quantitative bias analysis to epidemiologic data. Cham: Springer International Publishing; 2021. p. 141\u201395."},{"key":"1641_CR20","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1016\/j.jpainsymman.2021.04.012","volume":"62","author":"AS Kelley","year":"2021","unstructured":"Kelley AS, Hanson LC, Ast K, et al. The serious illness population: ascertainment via electronic health record or claims data. J Pain Symptom Manage. 2021;62:e148\u201355. https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.04.012.","journal-title":"J Pain Symptom Manage"},{"key":"1641_CR21","unstructured":"Optum Labs. Optum Labs and Optum Labs Data Warehouse (OLDW) Descriptions and Citation. Eden Prairie, MN: n.p. March 2023. PDF. Reproduced with permission from Optum Labs."},{"key":"1641_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/ppe.12863","volume":"36","author":"AK Regan","year":"2022","unstructured":"Regan AK, Arah OA, Sullivan SG. Performance of diagnostic coding and laboratory testing results to measure COVID\u201019 during pregnancy and associations with pregnancy outcomes. Paediatr Perinat Epidemiol. 2022;36:508\u201317. https:\/\/doi.org\/10.1111\/ppe.12863.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"1641_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s40264-021-01113-8","volume":"44","author":"K Moll","year":"2021","unstructured":"Moll K, Wong HL, Fingar K, et al. Validating claims-based algorithms determining pregnancy outcomes and gestational age using a linked claims-electronic medical record database. Drug Saf. 2021;44:1151. https:\/\/doi.org\/10.1007\/s40264-021-01113-8.","journal-title":"Drug Saf"},{"key":"1641_CR24","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/bdra.23573","volume":"106","author":"EC Ailes","year":"2016","unstructured":"Ailes EC, Simeone RM, Dawson AL, et al. Using insurance claims data to identify and estimate critical periods in pregnancy: an application to antidepressants. Birth Defects Res A Clin Mol Teratol. 2016;106:927\u201334. https:\/\/doi.org\/10.1002\/bdra.23573.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"1641_CR25","unstructured":"IIS Data Code Sets | CDC. 2023. https:\/\/www.cdc.gov\/vaccines\/programs\/iis\/code-sets.html. Accessed 28 Feb 2024"},{"key":"1641_CR26","volume-title":"Adults in all US states are now eligible for vaccination, hitting Biden\u2019s target Half have had at least one dose","author":"E Anthes","year":"2021","unstructured":"Anthes E, Ngo M, Sullivan E. Adults in all US states are now eligible for vaccination, hitting Biden\u2019s target Half have had at least one dose. The New York Times; 2021."},{"key":"1641_CR27","unstructured":"Centers for Disease Control and Prevention. New CDC data: COVID-19 vaccination safe for pregnant people. CDC. 2021. https:\/\/archive.cdc.gov\/www_cdc_gov\/media\/releases\/2021\/s0811-vaccine-safe-pregnant.html. Accessed 6 July 2024."},{"key":"1641_CR28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ije\/22.4.742","volume":"22","author":"CP Farrington","year":"1993","unstructured":"Farrington CP. Estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 1993;22:742\u20136. https:\/\/doi.org\/10.1093\/ije\/22.4.742.","journal-title":"Int J Epidemiol"},{"key":"1641_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/ije\/dyac013","volume":"52","author":"B Flannery","year":"2023","unstructured":"Flannery B, Andrews N, Feikin D, et al. Commentary: estimation of vaccine effectiveness using the screening method. Int J Epidemiol. 2023;52:19\u201321. https:\/\/doi.org\/10.1093\/ije\/dyac013.","journal-title":"Int J Epidemiol"},{"key":"1641_CR30","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/aje\/kwae045","volume":"193","author":"Y-H Chiu","year":"2024","unstructured":"Chiu Y-H, Huybrechts KF, Zhu Y, et al. Internal validation of gestational age estimation algorithms in health-care databases using pregnancies conceived through fertility procedures. Am J Epidemiol. 2024;193:1168\u201375. https:\/\/doi.org\/10.1093\/aje\/kwae045.","journal-title":"Am J Epidemiol"},{"key":"1641_CR31","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1016\/S1473-3099(24)00134-8","volume":"24","author":"K Kocher","year":"2024","unstructured":"Kocher K, Moosmann C, Drost F, et al. Adaptive immune responses are larger and functionally preserved in a hypervaccinated individual. Lancet Infect Dis. 2024;24:e272\u20134. https:\/\/doi.org\/10.1016\/S1473-3099(24)00134-8.","journal-title":"Lancet Infect Dis"},{"key":"1641_CR32","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7239a4","author":"H Razzaghi","year":"2023","unstructured":"Razzaghi H. Influenza, Tdap, and COVID-19 vaccination coverage and hesitancy among pregnant women\u2014United States, April 2023. MMWR Morb Mortal Wkly Rep. 2023. https:\/\/doi.org\/10.15585\/mmwr.mm7239a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1641_CR33","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2024.307899","author":"SL Rowe","year":"2025","unstructured":"Rowe SL, Sullivan SG, Munoz FM, et al. Uptake of recommended vaccines during pregnancy among publicly and privately insured people in the United States, December 2020\u2013September 2022. Am J Public Health. 2025. https:\/\/doi.org\/10.2105\/AJPH.2024.307899.","journal-title":"Am J Public Health"},{"key":"1641_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.12.022","volume":"42","author":"SE Oliver","year":"2024","unstructured":"Oliver SE, Wallace M, Twentyman E, et al. Development of COVID-19 vaccine policy\u2014United States, 2020\u20132023. Vaccine. 2024;42:125512. https:\/\/doi.org\/10.1016\/j.vaccine.2023.12.022.","journal-title":"Vaccine"},{"key":"1641_CR35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2102535","volume":"384","author":"E Goralnick","year":"2021","unstructured":"Goralnick E, Kaufmann C, Gawande AA. Mass-vaccination sites\u2014an essential innovation to curb the COVID-19 pandemic. N Engl J Med. 2021;384:e67. https:\/\/doi.org\/10.1056\/NEJMp2102535.","journal-title":"N Engl J Med"},{"key":"1641_CR36","unstructured":"Nirappil F, Sun LH, Achenbach J, et al. Coronavirus vaccines, once free, are now pricey for uninsured people. Washington Post. 2024."},{"key":"1641_CR37","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/ije\/dyi060","volume":"34","author":"AM Jurek","year":"2005","unstructured":"Jurek AM, Greenland S, Maldonado G, et al. Proper interpretation of non-differential misclassification effects: expectations vs observations. Int J Epidemiol. 2005;34:680\u20137. https:\/\/doi.org\/10.1093\/ije\/dyi060.","journal-title":"Int J Epidemiol"},{"key":"1641_CR38","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/aje\/kwac035","volume":"191","author":"JJ Yland","year":"2022","unstructured":"Yland JJ, Wesselink AK, Lash TL, et al. Misconceptions about the direction of bias from nondifferential misclassification. Am J Epidemiol. 2022;191:1485\u201395. https:\/\/doi.org\/10.1093\/aje\/kwac035.","journal-title":"Am J Epidemiol"}],"updated-by":[{"DOI":"10.1007\/s40264-026-01661-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000}}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01641-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-025-01641-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-025-01641-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T10:15:23Z","timestamp":1776334523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-025-01641-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1641"],"URL":"https:\/\/doi.org\/10.1007\/s40264-025-01641-7","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The conflict of interest statement has been revised.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40264-026-01661-x","URL":"https:\/\/doi.org\/10.1007\/s40264-026-01661-x","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AKR reports membership on a data safety monitoring board (DSMB) for matters unrelated to the presented research. SGS reports consulting for Astra-Zeneca, GSK, Sanofi, Pfizer, Moderna, CSL Seqirus, Novavax, and Evo Health on work unrelated to the presented research. FMM is an investigator in pediatric studies of coronavirus disease 2019 vaccines for Pfizer and Moderna and for a pediatric remdesivir study conducted by Gilead Sciences; serves as investigator on projects supported by a National Institutes of Health (NIH) contract for a Vaccine Treatment and Evaluation Unit and the Centers for Disease Control and Prevention (CDC) New Vaccine Surveillance Network; serves as a member of the DSMB for clinical trials conducted by Pfizer, Dynavax, Moderna, Meissa Vaccines, Virometix, and the NIH; and is a member of the American Academy of Pediatrics Committee of Infectious Diseases and the Immunization Expert Group of the American College of Obstetrics and Gynecology and cochair of the COVAX Maternal Immunization Working Group. SLR reports consulting for CSL Seqirus on work unrelated to the presented research. All other authors report no potential conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was determined not to be human subjects research because of the use of pre-existing, de-identified data and was therefore exempt from full Institutional Review Board review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"De-identified secondary data were used in this study, and consent to participate was not obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"During the conduct of the study, the first author (MMC) and AKR had full access to the study data and took responsibility for the integrity of the data and the accuracy of the data analysis. However, the authors do not have ongoing access to the data analyzed in this study, nor do they have permission to share the study data with other researchers.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Code for the simulated implications on vaccine safety and effectiveness is available online:\n                      \n                      . Code for other components of the study that has been edited to comply with Optum Labs policy is available upon request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AKR conceptualized the study and secured funding for the research. MMC analyzed the data, interpreted the results, and wrote the article. AKR, SLR, SGS, FMM, and OAA provided critical feedback on study design and article content. All authors reviewed and approved the final version of the article.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}